JP2024524851A5 - - Google Patents
Info
- Publication number
- JP2024524851A5 JP2024524851A5 JP2023574371A JP2023574371A JP2024524851A5 JP 2024524851 A5 JP2024524851 A5 JP 2024524851A5 JP 2023574371 A JP2023574371 A JP 2023574371A JP 2023574371 A JP2023574371 A JP 2023574371A JP 2024524851 A5 JP2024524851 A5 JP 2024524851A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- salt
- alkyl
- contacting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163209877P | 2021-06-11 | 2021-06-11 | |
| US63/209,877 | 2021-06-11 | ||
| US202163273326P | 2021-10-29 | 2021-10-29 | |
| US63/273,326 | 2021-10-29 | ||
| PCT/IB2022/055416 WO2022259222A1 (en) | 2021-06-11 | 2022-06-10 | Process for preparing an erk inhibitor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024524851A JP2024524851A (ja) | 2024-07-09 |
| JP2024524851A5 true JP2024524851A5 (https=) | 2025-06-18 |
Family
ID=82358522
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023574371A Pending JP2024524851A (ja) | 2021-06-11 | 2022-06-10 | Ｅｒｋ阻害剤を調製するプロセス |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240287051A1 (https=) |
| EP (1) | EP4352052A1 (https=) |
| JP (1) | JP2024524851A (https=) |
| KR (1) | KR20240021198A (https=) |
| CA (1) | CA3222540A1 (https=) |
| WO (1) | WO2022259222A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE068392T2 (hu) * | 2015-10-21 | 2024-12-28 | Otsuka Pharma Co Ltd | Benzolaktám vegyületek mint fehérje kináz gátlók |
| US20250049810A1 (en) | 2023-08-07 | 2025-02-13 | Revolution Medicines, Inc. | Methods of treating a ras protein-related disease or disorder |
| AU2024360465A1 (en) | 2023-10-12 | 2026-04-09 | Revolution Medicines, Inc. | Macrocyclic ras inhibitors |
| WO2025171296A1 (en) | 2024-02-09 | 2025-08-14 | Revolution Medicines, Inc. | Ras inhibitors |
| TW202547461A (zh) | 2024-05-17 | 2025-12-16 | 美商銳新醫藥公司 | Ｒａｓ抑制劑 |
| WO2025255438A1 (en) | 2024-06-07 | 2025-12-11 | Revolution Medicines, Inc. | Methods of treating a ras protein-related disease or disorder |
| WO2025265060A1 (en) | 2024-06-21 | 2025-12-26 | Revolution Medicines, Inc. | Therapeutic compositions and methods for managing treatment-related effects |
| WO2026006747A1 (en) | 2024-06-28 | 2026-01-02 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026015790A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026015801A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026015796A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026015825A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Use of ras inhibitor for treating pancreatic cancer |
| WO2026050446A1 (en) | 2024-08-29 | 2026-03-05 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026072904A2 (en) | 2024-09-26 | 2026-04-02 | Revolution Medicines, Inc. | Compositions and methods for treating lung cancer |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2396307T1 (sl) * | 2009-02-11 | 2015-02-27 | Merck Patent Gmbh | Novi amino azaheterockliäśni karboksamidi |
| HUE068392T2 (hu) | 2015-10-21 | 2024-12-28 | Otsuka Pharma Co Ltd | Benzolaktám vegyületek mint fehérje kináz gátlók |
| GB201706327D0 (en) | 2017-04-20 | 2017-06-07 | Otsuka Pharma Co Ltd | A pharmaceutical compound |
| US10717703B2 (en) * | 2017-08-21 | 2020-07-21 | Celgene Corporation | Processes for the preparation of (S)-tert-butyl 4,5-diamino-5-oxopentanoate |
| PE20201170A1 (es) * | 2017-11-01 | 2020-10-28 | Bristol Myers Squibb Co | Compuestos biciclicos en puente como moduladores del receptor farnesoide x |
| TW202110848A (zh) * | 2019-05-24 | 2021-03-16 | 大陸商江蘇恆瑞醫藥股份有限公司 | 取代的稠合雙環類衍生物、其製備方法及其在醫藥上的應用 |
| JP7688633B2 (ja) * | 2019-11-15 | 2025-06-04 | 武漢朗来科技発展有限公司 | Ｒｏｃｋ阻害剤及びその製造方法と用途 |
-
2022
- 2022-06-10 KR KR1020237045026A patent/KR20240021198A/ko active Pending
- 2022-06-10 JP JP2023574371A patent/JP2024524851A/ja active Pending
- 2022-06-10 EP EP22735999.9A patent/EP4352052A1/en active Pending
- 2022-06-10 CA CA3222540A patent/CA3222540A1/en active Pending
- 2022-06-10 WO PCT/IB2022/055416 patent/WO2022259222A1/en not_active Ceased
- 2022-06-10 US US18/568,772 patent/US20240287051A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024524851A5 (https=) | ||
| JP7749642B2 (ja) | Ｒｅｔｒｏｖｉｒｉｄａｅウイルス感染の処置において有用な治療用化合物を調製するための方法および中間体 | |
| JP2025503168A (ja) | 抗癌剤として有用なピラゾリル誘導体の合成プロセス | |
| AU2013271772A1 (en) | Synthesis of antiviral compound | |
| MX2010014224A (es) | Un proceso para la preparacion del promotor de apoptosis abt-263. | |
| ES2605638T3 (es) | Proceso Mejorado para fabricar 5-(2,6-di-4-morfolinil-4-pirimidinil)-4-trifluorometilpiridin-2-amina | |
| TW201829422A (zh) | ７Ｈ－吡咯并［２，３－ｄ］嘧啶衍生物的製造方法及其合成中間體 | |
| JP2013523760A5 (https=) | ||
| CA2987321A1 (en) | Tetrasubstituted alkene compounds and their use | |
| JP2014503001A5 (https=) | ||
| KR20150020214A (ko) | 하이드록실화 사이클로펜틸피리미딘 화합물 제조 방법 | |
| JP6118412B2 (ja) | 抗ウイルス化合物の合成 | |
| TW202024059A (zh) | 吡啶並〔２，３－ｄ〕嘧啶－７（８ｈ）－酮的合成 | |
| EP1478619B1 (en) | A process for preparing a phenylalanine derivative and intermediates thereof | |
| EP3091007A1 (en) | Process for the preparation of piperidine compounds | |
| JP2011510026A5 (https=) | ||
| SK5202000A3 (en) | Method for the preparation of (e)-n-(6,6-dimethyl-2-hepten-4- inyl)-n-methyl-1-naphthalenemethylamine (terbinaphin) | |
| JP2007519685A5 (https=) | ||
| JP4343260B2 (ja) | フルオロホウ素化合物およびそれからなる芳香環のアミノメチル化剤、ならびに前記アミノメチル化剤を用いたアミノメチル芳香環を有する化合物の製造方法 | |
| JP6321889B2 (ja) | イブチニブ中間体化合物、その製造方法及び用途 | |
| AU2006283297A1 (en) | Methods for the preparation of HCV polymerase inhibitors | |
| JP2006516588A5 (https=) | ||
| JP6389967B2 (ja) | インダゾール誘導体を作製する方法 | |
| CN108218908A (zh) | 一种新型雄激素受体拮抗剂的制备方法 | |
| CN107207518A (zh) | 生产稠合咪唑衍生物的工艺 |